![](https://d3ilqtpdwi981i.cloudfront.net/eWxQ-tu9mXBWm8gR0c1kmsok-Vg=/0x0:596x771/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/6b/b6/d3/6bb6d3ee-4580-4733-a652-cb36d551617a/ajh.v94.10.cover.jpg)
Article
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome
American Journal of Hematology
(2015)
Disciplines
Publication Date
January 6, 2015
DOI
10.1002/ajh.23981
Citation Information
Mazyar Shadman, Raya Mawad, Carol Dean, Tara L. Chen, et al.. "Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome" American Journal of Hematology Vol. 90 Iss. 6 (2015) p. 483 - 486 Available at: http://works.bepress.com/kathleen_shannondorcy/13/